2024-09-03 - Analysis Report
## Pfizer (PFE) Stock Analysis

**1. Performance vs. S&P 500**

Pfizer (PFE) is a pharmaceutical company that develops, manufactures, and markets drugs and vaccines. PFE's cumulative return is -26.27%, significantly underperforming the S&P 500 (VOO) with an 89.66% return. This results in a large divergence of -115.93, indicating that PFE has significantly underperformed the market. The relative divergence of 1.28 suggests that PFE's performance is currently at the worst point compared to the S&P 500 over the analyzed period. 

**2. Recent Price Action**

PFE is currently trading at $29.01.  The 5-day moving average is $28.84, the 20-day moving average is $28.85, and the 60-day moving average is $28.8. This suggests that the stock price is currently hovering near its recent moving averages.

**3. Technical Indicators**

- **RSI:**  At 60.69, PFE is in a slightly overbought territory. 
- **PPO:**  The PPO value of -0.02 suggests that the stock price is currently in a neutral territory with no significant momentum. 
- **Relative Divergence:**  The recent (20-day) relative divergence change of -11.82 indicates a short-term downtrend.  
- **Expected Return:** The expected return of 0.0% suggests that for the current investment, there is no significant expected return over the next 5 years.

**4. Recent Earnings and Outlook**

Pfizer's recent earnings have been mixed. The most recent earnings report shows an EPS of $0.60, surpassing the expected EPS of $0.458. This positive surprise indicates a potentially strong outlook. However, the company has struggled in previous quarters, with some earnings falling short of estimates.  

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-07-30 | 0.6 | 0.458 |
| 2024-05-01 | 0.82 | 0.516 |
| 2024-01-30 | 0.1 | -0.19 |
| 2023-10-31 | -0.17 | -0.32 |
| 2023-08-01 | 0.67 | 0.56 |

**5. Overall Analysis**

Pfizer has significantly underperformed the S&P 500 in the past. While the most recent earnings beat expectations, it has struggled in previous quarters. Technical indicators suggest a neutral to slightly overbought environment with short-term downtrend. The expected return is minimal, indicating that the stock may not offer significant gains in the near future. 

**6. Summary and Recommendation**

PFE's current performance is weak, with a significant underperformance compared to the market. While recent earnings beat expectations, the past performance has been inconsistent. Technical indicators suggest a neutral environment with a potential short-term downtrend. With a minimal expected return, investors may consider holding existing positions but should be cautious about new investments in PFE at this time. 
